Keyphrases
4T1 Breast Cancer
9%
Anti-DR5
18%
Antibody Therapy
9%
Antitumor Effect
18%
Apoptosis
100%
Associated Symptoms
9%
Berberine
100%
Breast Cancer
100%
Breast Cancer Model
18%
Cancer Cells
18%
Cancer-related
9%
Caspase-3 Activation
9%
Coptisine
9%
Diarrhea
9%
Evidence Support
9%
Fungal Infection
9%
Human Breast Cancer Cell Lines
9%
Induced Apoptosis
18%
Ligand-mediated
100%
Ligand-receptor Binding
9%
Lung Metastasis
9%
MDA-MB-468 Cells
9%
Murine Breast Cancer
9%
New Adjuvants
9%
PARP Cleavage
9%
Primary Tumor Growth
9%
Recombinant
18%
Therapeutic Monoclonal Antibody
9%
Treatment of Bacterial Infections
9%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
100%
Medicine and Dentistry
Adjuvant
10%
Antibody Therapy
10%
Bacterial Infection
10%
Berberine
100%
Breast Cancer
100%
Breast Cancer Cell Line
10%
Cancer Cell
20%
Cancer Model
20%
Caspase 3
10%
Coptisine
10%
Diarrhea
10%
In Vitro
20%
Lung Metastasis
10%
Malignant Neoplasm
20%
Monoclonal Antibody Therapy
10%
Mycosis
10%
Poly ADP Ribose Polymerase
10%
Primary Tumor
10%
Programmed Cell Death
100%
Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand
20%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
10%
Tumor Progression
10%
Pharmacology, Toxicology and Pharmaceutical Science
Adjuvant
10%
Bacterial Infection
10%
Berberine
100%
Breast Cancer
100%
Cancer Model
20%
Caspase 3
10%
Coptisine
10%
Diarrhea
10%
Lung Metastasis
10%
Malignant Neoplasm
40%
Monoclonal Antibody
10%
Murine
10%
Mycosis
10%
Primary Tumor
10%
Recombinant Tumor Necrosis Factor Related Apoptosis Inducing Ligand
20%
Tumor Growth
10%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
100%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand Receptor
10%